摘要
目的:观察磷酸奥司他韦治疗早期流感的疗效。方法:将144例早期流感病例,随机分成奥司他韦组72例,磷酸奥司他韦75 m g,2次/d,口服,疗程2-5 d;利巴韦林组72例,疗程3-7 d。结果:治疗前两组病情严重程度无显著差异。治疗后两组发热平均缓解时间比较差异有统计学意义(P〈0.05),奥司他韦组发热持续时间缩短。结论:奥司他韦治疗流感早期疗效确切。
Objective: To observe the effect of Oseltamivir in treating early influenza.Methods: 144 patients with early influenza were randomly divided into two groups: the Oseltamivir group and Ribavirin group.Patients in the Oseltamivir group took Oseltamivir 75 mg orally twice daily for 2~5 days,while patients in the Ribavirin group reveived treatment of ribavirin for 3~7days.Results: There shows no obvious differences in patients between the two groups in the severity of the disease before the treatment,but there is of statistical difference in the fever release time of the influenza patients in both groups after the treatment(P0.05),the fever remission time in patients in the Oseltamivir group is shorter.Conclusion: Oseltamivir is a effective treatment for early influenza.
出处
《华夏医学》
CAS
2010年第5期496-499,共4页
Acta Medicinae Sinica
关键词
磷酸奥司他韦
流感早期
疗效
oseltamivir
early influenza
curative effect